Study of ORL-1B in Patients With Biotinidase Deficiency
NCT03269045
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Biotinidase Deficiency
Interventions
DRUG:
ORL-1B
Sponsor
Orpha Labs